So that vitamin K status is reduced in patients with severe COVID‐19, and low vitamin K status seems to be associated with accelerated elastin degradation and vitamin K administration improves outcome in patients with COVID‐19 (Dofferhoff et al., 2020). This evidence concerns the gene ELN and COVID-19.